Dabrafenib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Dabrafenib and local guidelines before prescribing.

Kinase inhibitor

Mechanism

BRAF kinase inhibitor.

Uses

BRAF V600 melanoma, lung and thyroid cancers (with trametinib).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Pyrexia, rash, cardiomyopathy, new skin cancers, hyperglycaemia.

Interactions

CYP3A4 interactions.

Contraindications and cautions

Pregnancy

Monitoring

LVEF, skin, glucose

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Caution in severe hepatic impairment

Overdose and reversal

Supportive

Special advice

Fever pathway and skin checks.

More from the textbook: uses, cautions and other points
Where it is discussed in the book